1. A Prospective, Multicenter European Study on the Effects of Anatolian Propolis and Hypertonic Saline Combination Nasal Spray on Allergic Rhinitis Symptoms.
- Author
-
Manole F, Hoermann K, Passali D, Rombaux P, Maria Bellussi L, Rudenko M, Milkov M, Kopacheva-Barsova G, Prokopakis E, Chabolle F, Doulaptsi M, Bal C, and Cingi C
- Subjects
- Humans, Male, Female, Prospective Studies, Saline Solution, Hypertonic administration & dosage, Saline Solution, Hypertonic therapeutic use, Adult, Middle Aged, Treatment Outcome, Europe, Young Adult, Adolescent, Nasal Obstruction drug therapy, Administration, Intranasal, Aged, Nasal Sprays, Quality of Life, Propolis administration & dosage, Propolis therapeutic use, Rhinitis, Allergic drug therapy
- Abstract
Objectives: The current study examined the effectiveness of Rhinapi, a hypertonic saline nasal spray with Anatolian propolis added, on allergic rhinitis (AR) symptoms in a European population. Methods: Four hundred and forty AR patients (251 males and 189 females) from various European centers were enrolled. Nasal examination, overall symptom scores, individual AR symptoms (nasal discharge, sneezing, nasal itching, and nasal obstruction), and quality of life (QoL) were assessed before and after 3 weeks of treatment with Rhinapi, the nasal spray made of hypertonic saline with Anatolian propolis added (Bee&You, Istanbul, Turkey). Results: Rhinapi nasal drop use was associated with a substantial decrease ( P < .05) in AR symptom ratings, including nasal discharge, sneezing, nasal itching, and nasal obstruction. QoL scores showed a significant improvement ( P < .05), and the spray also alleviated swelling and improved concha color ( P < .05). Conclusion: Rhinapi, Anatolian propolis-added hypertonic saline nasal spray (Bee&You, Istanbul, Turkey), when used for 3 weeks, reduced AR symptom scores and improved QoL. Both the concha color and the edema were also enhanced., Competing Interests: Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
- Published
- 2024
- Full Text
- View/download PDF